These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1003411)

  • 21. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
    Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
    Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
    Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues.
    Osgood PF; Howes JF; Razdan RK; Pars HG
    J Med Chem; 1978 Aug; 21(8):809-11. PubMed ID: 691006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.
    Singer M; Ryan WJ; Saha B; Martin BR; Razdan RK
    J Med Chem; 1998 Oct; 41(22):4400-7. PubMed ID: 9784115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
    Gorriti MA; Rodríguez de Fonseca F; Navarro M; Palomo T
    Eur J Pharmacol; 1999 Jan; 365(2-3):133-42. PubMed ID: 9988095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols.
    Papahatjis DP; Nikas SP; Andreou T; Makriyannis A
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3583-6. PubMed ID: 12443781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and psychotropic activity of side-chain hydroxylated delta6-tetrahydrocannabinol metabolites.
    Ohlsson A; Agurell S; Leander K; Dahmén J; Edery H; Porath G; Levy S; Mechoulam R
    Acta Pharm Suec; 1979; 16(1):21-33. PubMed ID: 110030
    [No Abstract]   [Full Text] [Related]  

  • 28. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cannabinoid with cardiovascular activity but no overt behavioral effects.
    Adams MD; Earnhardt JT; Martin BR; Harris LS; Dewey WL; Razdan RK
    Experientia; 1977 Sep; 33(9):1204-5. PubMed ID: 891878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
    Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure--activity studies on tetrahydro- and hexahydrocannabinol derivatives.
    Skinner WA; Rackur G; Uyeno E
    J Pharm Sci; 1979 Mar; 68(3):330-2. PubMed ID: 423121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA).
    Nichols DE; Brewster WK; Johnson MP; Oberlender R; Riggs RM
    J Med Chem; 1990 Feb; 33(2):703-10. PubMed ID: 1967651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs.
    Wilson RS; May EL
    J Med Chem; 1975 Jul; 18(7):700-3. PubMed ID: 1151992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
    Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
    CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel, potent THC/anandamide (hybrid) analogs.
    Bourne C; Roy S; Wiley JL; Martin BR; Thomas BF; Mahadevan A; Razdan RK
    Bioorg Med Chem; 2007 Dec; 15(24):7850-64. PubMed ID: 17827022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
    Compton DR; Prescott WR; Martin BR; Siegel C; Gordon PM; Razdan RK
    J Med Chem; 1991 Nov; 34(11):3310-6. PubMed ID: 1659638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. delta7-Tetrahydrocannabinol, a non-psychotropic cannabinoid: structure-activity considerations in the cannabinoid series.
    Binder M; Edery H; Porath G
    Adv Biosci; 1978 Jul 22-23; 22-23():71-80. PubMed ID: 116883
    [No Abstract]   [Full Text] [Related]  

  • 40. Dichloroethyl carbamoyl ester of delta-9-tetrahydrocannabinol. Chemical synthesis and biological testing and evaluation as a potentially site-specific anti-tumor agent.
    Kaplan NC
    Sci Sin B; 1984 Oct; 27(10):1048-58. PubMed ID: 6098968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.